Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Nice work TH!

Indeed, Pfizer must work on its balance sheet. Except for the bad Flowie (new Flowie is ~1.37 vs 0.83 for the old), Pfizer's business looks fantastic. But then again, seeing those receivables grow 31.3% vs sales growth of 22.5% is somewhat worrisome. In the coming quarters, I really hope to see the company's balance sheet improve. With such a strong arsenal of existing products plus a great pipeline, I would expect a cleaner balance sheet at some point in the not-so-distant future. This is definitely something we must keep our eyes on.

-Matt
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.